The PROteolysis Targeting Chimera (PROTAC) technology has revolutionized the pharmaceutical landscape, particularly in oncology. With its unique mechanism of targeting and degrading specific proteins, PROTACs offer a promising approach to drug development. This article provides a detailed analysis of the PROTAC market size, explores the expansion of the PROTACs oncology market, and highlights...
0 Commentarios
0 Acciones
304 Views
0 Vista previa